NL7902444A - Therapeutisch werkzame stoffen; farmaceutisch prepa- raat; werkwijze voor het tegengaan of voorkomen van symptomen van een allergische reaktie in zoogdieren; werkwijze voor de bereiding van therapeutisch actieve verbindingen. - Google Patents

Therapeutisch werkzame stoffen; farmaceutisch prepa- raat; werkwijze voor het tegengaan of voorkomen van symptomen van een allergische reaktie in zoogdieren; werkwijze voor de bereiding van therapeutisch actieve verbindingen.

Info

Publication number
NL7902444A
NL7902444A NL7902444A NL7902444A NL7902444A NL 7902444 A NL7902444 A NL 7902444A NL 7902444 A NL7902444 A NL 7902444A NL 7902444 A NL7902444 A NL 7902444A NL 7902444 A NL7902444 A NL 7902444A
Authority
NL
Netherlands
Prior art keywords
therapeutically active
preventing
mammals
pharmaceutical preparation
allergic reaction
Prior art date
Application number
NL7902444A
Other languages
English (en)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NL7902444A publication Critical patent/NL7902444A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/73Unsubstituted amino or imino radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
NL7902444A 1978-04-03 1979-03-29 Therapeutisch werkzame stoffen; farmaceutisch prepa- raat; werkwijze voor het tegengaan of voorkomen van symptomen van een allergische reaktie in zoogdieren; werkwijze voor de bereiding van therapeutisch actieve verbindingen. NL7902444A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/892,714 US4192944A (en) 1978-04-03 1978-04-03 Optionally substituted 4-oxo-4H-pyrido[1,2-a]pyrimidine-3-N-(1H-tetrazol-4-yl)carboxamides and their use as antiallergy agents

Publications (1)

Publication Number Publication Date
NL7902444A true NL7902444A (nl) 1979-10-05

Family

ID=25400392

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7902444A NL7902444A (nl) 1978-04-03 1979-03-29 Therapeutisch werkzame stoffen; farmaceutisch prepa- raat; werkwijze voor het tegengaan of voorkomen van symptomen van een allergische reaktie in zoogdieren; werkwijze voor de bereiding van therapeutisch actieve verbindingen.

Country Status (15)

Country Link
US (1) US4192944A (nl)
JP (1) JPS54141797A (nl)
BE (1) BE875246A (nl)
CA (1) CA1117112A (nl)
CH (1) CH643256A5 (nl)
DE (1) DE2913295A1 (nl)
DK (1) DK153485C (nl)
FR (1) FR2423490A1 (nl)
GB (1) GB2019836B (nl)
IE (1) IE48278B1 (nl)
IT (1) IT1116537B (nl)
LU (1) LU81107A1 (nl)
NL (1) NL7902444A (nl)
SE (1) SE440652B (nl)
ZA (1) ZA791525B (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495189A (en) * 1975-11-27 1985-01-22 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. Condensed pyrimidines
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
IE51802B1 (en) * 1979-12-03 1987-04-01 Fujisawa Pharmaceutical Co Quinazoline derivatives,processes for their preparation and pharmaceutical compositions containing them
CA1157858A (en) 1979-12-03 1983-11-29 Ikuo Ueda Quinazoline derivatives
JPS63183581A (ja) * 1985-10-03 1988-07-28 Tokyo Tanabe Co Ltd ピリド〔1,2−a〕ピリミジン誘導体、その製造法及びそれを有効成分とするアレルギ−疾患治療薬
HU201551B (en) * 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same
US6295995B1 (en) * 2000-04-07 2001-10-02 Irene D. Ewaka Permanently covered rigid or semi-rigid mounting piece for an article of fashion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3072485A (en) * 1960-08-24 1963-01-08 Eastman Kodak Co Optically sensitized azido polymers for photomechanical resist compositions
AT302311B (de) * 1966-11-02 1972-09-15 Chinoin Gyogyszer Es Vegyeszet Verfahren zur herstellung von homopyrimidazol-derivaten und deren saeureadditionssalzen und quaternaeren ammoniumsalzen
US3960847A (en) * 1972-04-17 1976-06-01 E. R. Squibb & Sons, Inc. 9-Substituted-4-oxopyrido(1,2-α)pyrimidine-3-carboxylic acids and derivatives thereof
US3929787A (en) * 1974-04-22 1975-12-30 Squibb & Sons Inc 6,7,8,9-Tetrahydro-pyrido(1,2-a)pyrimidin-4-ones
US4017625A (en) * 1975-08-01 1977-04-12 Pfizer Inc. Anti-allergic N-(5-tetrazolyl)-1-oxo-1H-6-alkoxypyrimido-[1,2-a]quinoline-2-carboxamides and intermediates therefor
SU685156A3 (ru) * 1975-08-01 1979-09-05 Пфайзер Инк (Фирма) Способ получени -(5-тетразолил(1-оксо-1н-пиримидо-)1,2-а) хинолин-2-карбоксамида
HU173438B (hu) * 1975-11-27 1979-05-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija novykh proizvodnykh 4-okso-1,6,7,8-/tetragidro-4h-pirido/1,2/pirimidina s zaderzhivajuhhejj vozgoranie aktivnot'ju i protivosvertivajuhhem effektom
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones

Also Published As

Publication number Publication date
IT7948569A0 (it) 1979-04-02
SE440652B (sv) 1985-08-12
JPS6256874B2 (nl) 1987-11-27
IE48278B1 (en) 1984-11-28
DE2913295C2 (nl) 1988-09-22
US4192944A (en) 1980-03-11
FR2423490B1 (nl) 1982-03-19
JPS54141797A (en) 1979-11-05
BE875246A (fr) 1979-10-01
GB2019836B (en) 1982-06-03
IE790950L (en) 1979-10-03
CA1117112A (en) 1982-01-26
SE7902915L (sv) 1979-10-04
DK153485B (da) 1988-07-18
LU81107A1 (fr) 1979-11-07
FR2423490A1 (fr) 1979-11-16
IT1116537B (it) 1986-02-10
CH643256A5 (de) 1984-05-30
DK153485C (da) 1988-11-21
DK130079A (da) 1979-10-04
ZA791525B (en) 1980-11-26
DE2913295A1 (de) 1979-10-18
GB2019836A (en) 1979-11-07

Similar Documents

Publication Publication Date Title
NL166460C (nl) Werkwijze voor de bereiding van zeer zuiver tereftaalzuur.
NL7605405A (nl) Werkwijze voor het bereiden van farmacologisch actieve verbindingen.
NL171260C (nl) Werkwijze voor de bereiding van zuuranhydriden.
NL182217C (nl) Werkwijze voor de bereiding van 2-oxo-3-arylpropionzuur.
NL7510620A (nl) Werkwijze voor de bereiding van farmacologisch actieve imidazo (1,5-a) (1,4) diazepineverbin- dingen.
NL186676C (nl) Werkwijze voor het bereiden of vervaardigen van een aescine-bevattend farmaceutisch preparaat; gevormd farmaceutisch preparaat.
NL185442C (nl) Werkwijze voor de bereiding van rodenticidepreparaten en werkwijze voor de bereiding van de werkzame bestanddelen daarvan.
NL7600283A (nl) Werkwijze voor de bereiding van oxaalzuur en esters daarvan.
NL7902444A (nl) Therapeutisch werkzame stoffen; farmaceutisch prepa- raat; werkwijze voor het tegengaan of voorkomen van symptomen van een allergische reaktie in zoogdieren; werkwijze voor de bereiding van therapeutisch actieve verbindingen.
NL7700425A (nl) Werkwijze voor de bereiding van preparaten en stoffen tegen maagzuur en maagzweren.
NL7705855A (nl) Werkwijze voor het bereiden van farmacologisch werkzame gesubstitueerde benzamiden, alsmede deze verbindingen bevattende farmaceutische preparaten.
NL7607572A (nl) Werkwijze voor de bereiding van zuiver druive- zuur en van mesowijnsteenzuur.
NL7610480A (nl) Werkwijze ter bereiding van hypolipemische ver- bindingen alsmede farmaceutische preparaten die deze verbindingen als actieve component bevatten.
NL190524C (nl) Werkwijze voor het bereiden van penicilline-esters.
NL7601450A (nl) Werkwijze voor de bereiding van zure universeel toepasbare reinigingsmiddelen.
NL183898C (nl) Werkwijze voor de bereiding van cefamycine c.
NL7603594A (nl) Werkwijze voor het bereiden van carbonzuuramiden, alsmede de toepassing daarvan als farmaceutische preparaten.
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
NL7608491A (nl) Werkwijze voor het bereiden van geneesmiddelen en farmacologisch actieve verbindingen.
NL7608344A (nl) Werkwijze voor de bereiding van korunddeeltjes.
NL7904056A (nl) Werkwijze voor de bereiding van arylazijnzuurderivaten.
NL7610166A (nl) Werkwijze voor de bereiding van zure microbi- ciden.
NL7608822A (nl) Werkwijze voor de bereiding van beheenzuuresters.
NL7602544A (nl) Werkwijze voor de bereiding van optisch aktief fenylglycine.
NL7904202A (nl) Werkwijze voor de bereiding van isocyanaten.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BRISTOL-MYERS SQUIBB COMPANY

BV The patent application has lapsed